NRXBF
NurExone Biologic Inc., a pharmaceutical technology company. It engages in the development of an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. Show More...